Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▼ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Enanta Pharmaceuticals Inc. | 6 | 4 | 0 | 0 | €13.80 | €25.58 | 85.348% |
| Immunogen Inc. | 4 | 0 | 0 | 0 | €28.97 | - | - |
| Insmed Inc. | 42 | 0 | 9 | 0 | €68.00 | €75.67 | 11.279% |
| Rigel Pharmaceutical Inc. | 14 | 0 | 1 | 0 | €0.74 | €13.82 | 1767.203% |
| Amneal Pharmaceuticals Inc | 1 | 1 | 0 | 0 | €6.80 | €10.00 | 47.059% |
| Savara Inc. | 1 | 0 | 0 | 0 | €4.20 | €5.00 | 19.048% |
| Puma Biotechnology Inc. | 1 | 0 | 1 | 0 | €3.64 | - | - |
| Catalent Inc. | 1 | 0 | 0 | 0 | €53.88 | €55.00 | 2.079% |
| Intellia Therapeutics Inc | 17 | 1 | 0 | 0 | €25.00 | €60.53 | 142.138% |
| Hutchison China MediTech Ltd ADR | 4 | 0 | 0 | 0 | €18.60 | €33.46 | 79.867% |
| AbbVie Inc. | 31 | 0 | 7 | 0 | €169.92 | €176.90 | 4.108% |
| Natural Alternat. | 21 | 1 | 3 | 0 | €5.05 | - | - |
| Merck KGaA | 3 | 2 | 0 | 1 | €159.20 | €146.00 | -8.291% |
| Avadel Pharmaceuticals plc ADR | 1 | 0 | 0 | 0 | €15.10 | €23.00 | 52.318% |
| Novartis AG ADR | 3 | 0 | 1 | 0 | €101.50 | €112.40 | 10.736% |
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | €136.05 | €130.00 | -4.447% |
| Acadia Pharmaceuticals | 29 | 1 | 2 | 0 | €17.14 | €31.28 | 82.554% |
| MacroGenics Inc. | 12 | 0 | 0 | 0 | €5.15 | €12.42 | 141.256% |
| Viatris Inc. | 2 | 0 | 0 | 0 | €11.00 | €12.00 | 9.141% |
| Repligen Corp. | 13 | 0 | 1 | 0 | €124.45 | €182.96 | 47.015% |
| Biocryst Pharmaceuticals | 9 | 0 | 0 | 0 | €7.07 | €11.05 | 56.210% |
| Adaptimmune Therapeutics PLC ADR | 2 | 1 | 2 | 1 | €1.23 | €2.00 | 62.602% |
| Alnylam Pharmace. | 44 | 0 | 2 | 0 | €219.00 | €253.95 | 15.961% |
| Fagron N.V. | 1 | 0 | 0 | 0 | €18.74 | €20.00 | 6.724% |
| TG Therapeutics Inc. | 21 | 2 | 0 | 0 | €18.07 | €28.06 | 55.310% |